Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

2.16USD
18 Jun 2018
Change (% chg)

$0.05 (+2.37%)
Prev Close
$2.11
Open
$2.11
Day's High
$2.17
Day's Low
$2.11
Volume
5,924
Avg. Vol
54,197
52-wk High
$7.68
52-wk Low
$1.84

Chart for

About

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $56.67
Shares Outstanding(Mil.): 23.51
Dividend: --
Yield (%): --

Financials

  SNSS.OQ Industry Sector
P/E (TTM): -- 84.11 32.75
EPS (TTM): -1.94 -- --
ROI: -174.35 1.56 14.38
ROE: -- 2.43 16.07

BRIEF-Sunesis Pharmaceuticals Qtrly Loss Per Share $0.21

* SUNESIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

08 May 2018

BRIEF-Sunesis Pharmaceuticals Announces Cancellation Of Presentation And Webcast At Cowen & Company 38Th Annual Health Care Conference

* SUNESIS PHARMACEUTICALS ANNOUNCES CANCELLATION OF PRESENTATION AND WEBCAST AT COWEN & COMPANY 38TH ANNUAL HEALTH CARE CONFERENCE

13 Mar 2018

BRIEF-Sunesis Pharma Qtrly Loss Per Share $0.21

* SUNESIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

08 Mar 2018

BRIEF-Boxer Capital Llc Reports 6.2 Percent Passive Stake In Sunesis Pharmaceuticals Inc

* BOXER CAPITAL, LLC REPORTS 6.2 PERCENT PASSIVE STAKE IN SUNESIS PHARMACEUTICALS INC AS OF FEBRUARY 21, 2018 Source text: (http://bit.ly/2H6YWUT) Further company coverage:

05 Mar 2018

Competitors

  Price Chg
Eisai Co., Ltd (4523.T) ¥8,094 -80.00
Johnson & Johnson (JNJ.N) $120.66 -1.95
Novartis AG (NOVN.S) CHF75.60 +0.10
Pfizer Inc. (PFE.N) $35.84 -0.52
Merck & Co., Inc. (MRK.N) $60.70 -1.33
Celgene Corporation (CELG.OQ) $77.31 -0.77

Earnings vs. Estimates